Drug resistance after cessation of efavirenz-based antiretroviral treatment started in pregnancy.

Globahan Ajibola Christopher F Rowley Dorcas Maruapula Jean Leidner Kara Bennett Kathleen M Powis Roger L Shapiro Shahin Lockman

Published in: Southern African journal of HIV medicine (2020)

Viral rebound was slow following cessation of EFV/FTC/TDF in the postpartum period. Use of an FTC/TDF tail after stopping EFV was associated with the lower prevalence of subsequent NNRTI drug resistance mutation.

Keyphrases

hiv infected
hiv infected patients
sars cov
antiretroviral therapy
human immunodeficiency virus
risk factors
hiv aids
preterm birth
pregnancy outcomes
pregnant women
hepatitis c virus
replacement therapy
men who have sex with men